SPHK2 and SPNS2 may serve as biomarkers for UC, offering new insights into diagnosis and inflammation control. Tiny particles in cow colostrum reduced eczema symptoms in mice, pointing to a potential new natural therapy. Study finds early lebrikizumab response in AD linked to lower inflammation—may guide personalized treatment plans.